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ABSTRACT  51 
Endovascular aneurysm sealing (EVAS) using the Nellix™ System was introduced in 52 
clinical practice with the aim of reducing the incidence of complications such as migration, 53 
endoleaks and reinterventions following conventional endovascular aneurysm repair 54 
(EVAR). Although, initial efficacy data on this device have been encouraging, EVAS has 55 
also demonstrated to undergo adverse events.  56 
Herein, we report a case of Nellix graft explant due to endobags shrinkage after bubbles 57 
air reabsorption leading to proximal type I A endoleak and stent migration. The focus of 58 
this article is on the importance of a more assiduous surveillance of this new device, in 59 
particular in those cases with air into the endobags immediately after the procedure; this 60 
surveillance should be aimed to timely identify complications which can otherwise lead to 61 
consequences that require open conversion. 62 
 63 
INTRODUCTION  64 
Type I endoleaks (ELs) are one of the most frequent complications after endovascular 65 
abdominal aortic repair (EVAR) with an incidence of 5% to 25%, related to aneurysm 66 
growth and rupture and usually require treatment.   67 
In 2013, EndoVascular Aneurysm Sealing (EVAS), using the Nellix system (Endologix, 68 
Irvine, CA, USA) was introduced in Europe to treat infrarenal abdominal aortic 69 
aneurysms (AAAs)1 with the aim of reducing the risk of complications, particularly any 70 
type of endoleaks and secondary interventions following EVAR.  71 
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EVAS is as a novel approach to AAA repair that is conceptually very different from EVAR 72 
since it addresses the principles of complete anatomic apposition to achieve sealing of 73 
AAA without any active fixation means. 74 
Although long-term data from the international studies have not been published after five 75 
years from its introduction in clinical practice, preliminary and mid-term results had 76 
showed good outcomes with a low rate of device-related adverse events, with a 3% 77 
reported incidence of type 1A ELs. 2,3,4   78 
However, the polymer-filled endobags of Nellix device obliterates the aneurysmal sac, 79 
forming a cast of the lumen of the aorta and iliac arteries, and therefore the type 1A ELs 80 
following EVAS may significantly differ in characteristics and behavior from those after 81 
EVAR. This explains the need for a specific classification of these endoleaks as suggested 82 
by van den Ham et al, who included in this classification the possibility of AAA 83 
pressurization with no visible endoleak. 5  84 
The peculiar characteristics of these endoleaks may imply different outcomes in terms of 85 
aneurysm rupture and stent-graft migration, which are still poorly understood.  86 
Herein, we report a case of Nellix graft explant due to a type I A endoleak and migration 87 
to discuss the main concerns of these complications. 88 
 89 
CASE REPORT 90 
This is a report of a 72-years-old male patient admitted at the department of Vascular 91 
Surgery on December 2013, for an abdominal aortic aneurysm (AAA) associated with a 92 
right common iliac artery (CIA) aneurysm (Fig. 1). The previous year, the patient had been 93 
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affected by arterial hypertension (WHO II), hypercholesterolemia and was submitted to 94 
percutaneous transluminal angioplasty (PTCA) and stenting with drug eluting stent (DES) 95 
of the obtuse marginalis artery for an acute coronary syndrome (ACS). The patient was 96 
deemed at high risk for open surgery due to his age and co-morbidities. 97 
The preoperative CTA showed an infrarenal AAA with a maximum diameter of 54 mm, 98 
with poor parietal thrombus apposition. The thrombus index (TI) calculated dividing 99 
maximum aneurysm sac diameter for the maximum flow lumen diameter was 1.38.  100 
The neck length was 24 mm, measured from the left renal artery (4 mm lower than the 101 
right renal artery), its proximal and distal diameters respectively of 22 and 25 mm the 102 
suprarenal and infrarenal neck angle was of 35 and 45 degrees, respectively, with no 103 
thrombus or calcification.  104 
The right CIA had a maximum diameter of 30 mm, and a length 57 mm, with patent 105 
internal iliac artery, the pre-bifurcation diameter was of 13 mm. The length between the 106 
lower renal artery and the iliac bifurcation was of 163 mm.  107 
The left CIA had a maximum diameter of 21 mm, and a length 35 mm, with no patency of 108 
internal iliac artery and angulated origin of external iliac artery, with a diameter of 10 mm. 109 
The length between the lower renal artery and the iliac bifurcation was of 141 mm (Fig. 2). 110 
The aorto-iliac anatomy was within the instructions for use (IFU) for the Nellix device 111 
(Endologix Inc., Irvine, California, USA) at the time.  112 
The Nellix device was chosen to prevent the risk of type II endoleaks related to the 113 
patency of four pairs of lumbar arteries and of the inferior mesenteric artery emerging 114 
from the aneurysmal sac.  115 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Thus, the patient underwent the EVAS procedure using a 160x10 mm and a 140x10 mm 116 
module Nellix devices with 70 mL of polymer with an intrasac pressure of 210 mmHg. A 117 
pre-filling with saline solution was performed. On the left axis, to smooth the angle and to 118 
avoid any possible limb occlusion, the Nellix stent was extended using a Gore Viabahn 119 
stent graft (50x10 mm) landed in external iliac artery. Completion angiography 120 
demonstrated proper positioning of the device with total aneurysm sealing.  121 
A post-operative CTA demonstrated the placement of Nellix stents, aligned 4 mm lower 122 
than the left renal artery, without endoleak (Fig. 3), although air bubbles were detected in 123 
both endobags (Fig. 4).  124 
The patient was enrolled in our follow-up protocol for EVAS including Duplex Scanning 125 
(DUS) before discharge, at 3, 6, 12 months after the procedure and annually thereafter; an 126 
MRI or CTA control was carried out at 6, 12 and 24 months of follow-up and after this 127 
period only if DUS showed complications or was not diagnostic. The three years follow-up 128 
DUS showed high-flow type 1a endoleak with aneurysm growth; as a consequence of 129 
these US findings, a confirmation CTA was performed which also showed the proximal 130 
caudal migration (>10mm), lateral bending of both stents, inhomogeneities of the mural 131 
thrombus and both proximal neck and distal right landing zone enlargement.  The aortic 132 
aneurysm and the right common iliac maximum diameters were 90 mm and 40 mm, 133 
respectively (Fig. 5).  134 
The use of the MRI in the follow-up protocol of the patients undergoing EVAS was mainly 135 
aimed at studying the behavior of the mural thrombus and the aneurysm wall. Despite no 136 
signs of any complication were detected at that time during the first two years of follow-137 
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up, on the retrospective analysis of the 2-year MRI scans there was measured neither 138 
significant sac enlargement nor significant proximal caudal migration. However on MR 139 
imaging, a small sickle shaped enhancement between the two endobags was detected 140 
suggesting the presence of a low-flow endoleak that was initially buffered by the Nellix 141 
system with subsequent apposition of new thrombus (Fig. 6).     142 
Open conversion was deemed absolutely necessary. Via transperitoneal approach, the 143 
proximal aortic control was obtained by cross-clamping the infrarenal aorta. Opening the 144 
aneurysmal sac, a thick parietal thrombus was noted; both endobags were undamaged 145 
although the polymer was predominantly dislocated in the proximal extremity rather than 146 
in the distal one of each endobag (Fig. 7a).  147 
Aorto-bi-iliac reconstruction was performed with a bifurcated Dacron graft sewn to the 148 
infrarenal aorta proximally and the iliac vessels distally. The left iliac Viabahn stent was so 149 
tenaciously adherent to the arterial wall, thus the distal anastomosis was performed to the 150 
residual distal stent frame after cutting its proximal segment (Fig. 7b).  151 
The post-operative course was uneventful and the patient was discharged in good clinical 152 
condition, on the sixth post-op day. One-year CTA control after Nellix explantation 153 
showed the patency of the aorto-iliac bypass (Fig. 7c).  154 
 155 
DISCUSSION 156 
Endovascular aneurysm repair (EVAR) is currently the first line therapy for abdominal 157 
aortic aneurysms.  Although initially utilized in patients deemed high risk for open repair, 158 
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EVAR is now widely applied in most patients with suitable aneurysm morphology and 159 
anatomy, regardless of the patient's surgical risk.6  160 
Nonetheless, long-term data demonstrate high reintervention rates after EVAR, resulting 161 
in higher costs compared with surgical repair.7  162 
Endoleaks are the most frequent complication requiring secondary intervention, after 163 
EVAR.8  164 
On this backdrop, EVAS with the Nellix device has been designed to minimize the risk of 165 
device-related adverse events including all types of endoleaks and endograft migration.  166 
The analysis of the two-year results of the FORWARD IDE trial have reported a freedom 167 
from all-cause mortality of 94%, a freedom from type IA endoleaks of 97.5% and a type I 168 
endoleak prevalence of 1.9%.9   169 
Consistently with these data, the Italian IRENE retrospective observational study reported 170 
a freedom from aneurysm-related reintervention of 98.3% at 1 month and of 94.7% at 12 171 
months of follow-up; the rates of early and late type IA endoleak were 0.3% and 1.4%, 172 
respectively and the reintervention incidence was 3.7%, that included 1.4% of surgical 173 
open conversions.10  174 
  175 
Although the low reported incidence of type 1A endoleak after Nellix EVAS, these 176 
endoleaks are one of the major concerns of EVAS because they are mostly high-pressure 177 
leaks and may lead to late rupture of aneurysms. 178 
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As stated by Holden et al., a type I endoleak may be very subtle due to the device design 179 
and difficult to differentiate from contrast in the endobag.11 180 
 181 
In EVAS, the type 1A ELs detected on completion angiography or on the first 182 
postoperative imaging control are usually the result of incomplete procedural seal at the 183 
proximal neck or within the aneurysm sac. Later type I endoleaks are related to several 184 
factors, including degeneration and dilation of the neck and changes in either aortic or 185 
device morphology (i.e. endobags shape) with loss of seal.12  186 
 187 
This complication may also be related to suboptimal deployment of Nellix system, 188 
resulting in an insufficient coverage at the proximal aortic neck.13   189 
As previously reported, the maximum diameter of the aneurysm may remain unchanged 190 
despite a persisting Type 1 endoleak, when it fills the limited space between the endobags 191 
and has an outflow via the inferior mesenteric artery or lumbar arteries which reduces the 192 
pressurization of the aneurysmal sac and the risk of AAA rupture.14,15  193 
Due to the absence of active proximal fixation of EVAS, a persistent type I endoleak with 194 
no outflow via collateral vessels may cause continued pressurization and significant 195 
increase of the proximal segment of the aneurysm resulting in proximal caudal migration 196 
of the stents within the aneurysm sac.  197 
However, the treatment of type I Els is always advisable assuming that they have the 198 
potential for sac enlargement and ultimately rupture.   199 
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Distraction forces may act at the proximal level of the Nellix device differently from a 200 
standard endovascular device and drive the endobags through the sac thrombus causing 201 
migration. As suggested by Argani et al, the Nellix endograft is exposed to external 202 
factors, that during day-to-day activities cause oscillating movements which, in time, may 203 
contribute to endograft instability and migration. 16 204 
This may result in the loss of the proximal sealing and a subsequent endoleak developing 205 
alongside the endobag within the aortic neck.17  A higher deployment of the Nellix system 206 
would have probably ensured a safer interface between the bag and the aortic wall and  207 
potentially prevent  bag slippage and distal migration of device components. 208 
The etiology of the late type 1A endoleaks reported in this article has not been fully 209 
cleared and it was retrospectively researched analyzing and comparing post-operative and 210 
subsequent follow-up imaging, including both CTA and MRI scans.  211 
It was probably due to two sequential factors:  the loss of seal in the proximal neck with 212 
subsequent continued aneurysm growth and distal translocation of the stents within the 213 
aneurysm sac. 214 
During the first year of follow-up, the imaging controls did not show any complications 215 
with the exception of the presence of air bubbles inside the endobags on the 1-month post-216 
operative CTA.  217 
According to literature, a small amount of air inadvertently introduced during the 218 
procedure, could be often seen on early post-operative contrast CT images; in a minority 219 
of cases, these air bubbles can persist at the 1-month stage but usually should not be 220 
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visible after 3 or 6 months, because it diffuses across the endobag and is replaced by fluid, 221 
probably from the periaortic extracellular space.18   222 
In the reported case, the 1-year CT scans demonstrated the shrinkage of both endobags; to 223 
confirm this, the total prosthetic volume calculated using the Osirix volume rendering 224 
tool, was 102.37 cm3 and it was reduced of 4,92% when compared to the early post-225 
operative CT. With the same method, we calculate the volume of the air bubbles that was 226 
4,13 cm3 and was comparable with the lacking volume. 227 
Based on these findings and in accordance with the literature, we hypothesize that the 228 
endobags shrinkage was caused by reabsorption of the air bubbles that were not replaced 229 
by fluid or polymer expansion.  230 
In addition, according to what was suggested by McWilliams et al. 19, the Hounsfield Unit 231 
measurement demonstrated a reduction in radiodensity of the polymer inside the 232 
endobags, from +189 to +100 HU.  233 
No proximal caudal migration, proximal neck enlargement or distal landing zone 234 
dilatation were associated to the endobag shrinkage on both CT and MRI subsequent 235 
controls. 236 
The post-operative imaging of Nellix failure may be challenging and sac pressurization 237 
and rupture may occur in the absence of a visible endoleak, as confirmed by Harrison et 238 
al. 20 239 
During the third year of follow-up, the DUS and the subsequent contrast CT control 240 
clearly showed a high-flow type IA EL combined with a dramatic distal dislocation of the 241 
two stents and enlargement of the aneurysm sac.    242 
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We have not reliably identified the cause of these complications; anyhow, it is conceivable 243 
that shrinkage of endobags caused the loss of the proximal sealing of the Nellix system 244 
and consequent endoleak alongside the endobag within the aortic neck which was initially 245 
unrecognized; the decrease in volume of endobags led to a reduction of the support for the 246 
stents and their caudal dislocation.  247 
In fact, as demonstrated by mechanical and computational fluid dynamic tests, the less the 248 
stents are surrounded by polymer, the less resistant they are to lateral bending. Also, vice 249 
versa the less thrombus is present in the aneurysmal sac, the more polymer can be 250 
introduced, providing support for the stents, because both blood flow downward force on 251 
the polymer-filled endobags and lateral acceleration force within curvatures in the stent-252 
grafts could contribute to loss of proximal stent-graft attachment, which could cause a 253 
type Ia endoleak to open adjacent to the endobag.21,22  254 
 255 
Although proximal Nellix-in-Nellix extension possibly with chimneys can be used to treat 256 
caudally migrated endograft and consequent type Ia endoleak 23, but this approach should 257 
be reserved to high-risk patients because the long-term efficacy remains still unproven. 24 258 
Thus, open conversion is the safest choice.  259 
 260 
Conversion to open repair of AAA after EVAS with Nellix system has rarely been reported 261 
and the explant due to a type IA endoleak and device migration has been even rarer.  262 
Lee et coll. has been the first to discuss two Nellix endograft explants required for 263 
endoleak and proximal caudal migration of the stent frames.25  264 
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Explantation of conventional endografts can be technically difficult due to suprarenal 265 
fixation stents and barbs. Conversely, in this case the absence of proximal active fixation 266 
system made the late explantation easy and quick to perform, without any wall damage at 267 
the level of aortic neck. At contrary of other endografts, we did not observe any periaortic 268 
inflammation and fibrosis provoked by the Nellix device at the time of its explantation. 269 
This is in line with our previously reported findings of no perioartic reaction to Nellix 270 
endograft graft demonstrated with MRI controls.26 271 
 272 
CONCLUSION  273 
The preliminary and mid-terms results of the real-world multicenter studies have 274 
demonstrated that EVAS with Nellix is a promising technique for treating AAAs. This 275 
device platform provided acceptable procedure-related mortality with low overall 276 
complication and reintervention rates. However, the more recent data highlight that 277 
migration is one of the main causes of EVAS failure. This complication may appear late, 278 
even after years of apparent stability. Therefore, the safety of EVAS remains under 279 
scrutiny. 280 
Post-operative surveillance of Nellix stent grafts is crucial to identify features of failure but 281 
evaluation of complications after a Nellix procedure can be challenging.  282 
The focus of this article is on the early recognition and treatment of type IA endoleaks 283 
before they lead to the migration of the stent frames. Another crucial point is that the 284 
initial presence of air bubbles within the endobags may not be harmless since their 285 
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reabsorption can lead to modification of their volume and shape with subsequent loss of 286 
Nellix device sealing and proximal type I endoleak.  287 
The reported case reinforces the current evidence that EVAS with the Nellix device needs 288 
a careful and rigorous surveillance which should include Duplex ultrasound controls 289 
combined with a yearly MRI or CT imaging.  This multimodality protocol of follow-up is 290 
aimed to timely identify complications such as type I endoleaks and migration requiring 291 
surgical conversion when misconceived.   292 
In case of open conversion, the Nellix explantation is easier than other devices’, due to the 293 
absence of proximal fixation means and the lack of periaortic inflammation.  294 
 295 
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Figures legend:  389 
 390 
Fig. 1 Aneurysm morphology in 3D reconstruction  391 
Fig. 2 The preoperative aneurysm sizing report 392 
Fig. 3 Post-operative CTA with no endoleak detectable, in coronal scans (a) and in sagittal 393 
scans (b) 394 
Fig. 4 Post-operative CTA showing the presence of air bubbles inside the endobags, and 395 
the comparison with 1 years CTA 396 
Fig. 5 Three-years follow-up scans showing type 1s3 endoleak, in 3D reconstruction (a), 397 
sagittal reconstructions (b), coronal scans (c). In d, the aneurysmal sac maximum diameter 398 
is shown 399 
Fig. 6 MRI findings: comparison between 6 months (a), 1 year (b) and two years (c) 400 
Fig. 7 Intraoperative pictures: at the aneurysmal sac opening, thick parietal thrombus and 401 
intact endobag are shown (a).  After manipulation and explantation, the endobags 402 
presented a yin-yang conformation with more polimer at the proximal extremities and less 403 
at the distal ones. Aorto-bisiliac bypass (c) 404 
 405 
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